State Street Corp Adma Biologics, Inc. Transaction History
State Street Corp
- $2.25 Trillion
- Q2 2024
A detailed history of State Street Corp transactions in Adma Biologics, Inc. stock. As of the latest transaction made, State Street Corp holds 8,059,930 shares of ADMA stock, worth $156 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,059,930
Previous 10,553,353
23.63%
Holding current value
$156 Million
Previous $69.7 Million
29.37%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding ADMA
# of Institutions
265Shares Held
178MCall Options Held
535KPut Options Held
21.2K-
Black Rock Inc. New York, NY18.6MShares$362 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.5MShares$281 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA13.2MShares$255 Million0.03% of portfolio
-
Nuveen Asset Management, LLC Chicago, IL8.93MShares$173 Million0.03% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY6.82MShares$132 Million0.08% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.81B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...